The influence of corticosteroids on the perception of dyspnea in asthma

Respiratory Medicine

Volumn 101, Issue 6, 2007, Pages 1079-1087

  von Leupoldt, Andreas ^a   Kanniess, Frank ^b   Dahme, Bernhard ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b KRANKENHAUS GROSSHANSDORF   (Germany)

Author keywords

Asthma; Breathlessness; Corticosteroid; Dyspnea; Inflammation; Perception

Indexed keywords

BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE; FORMOTEROL; METHYLPREDNISOLONE; PLACEBO; PREDNISONE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE;

ASTHMA; BEHAVIOR DISORDER; BONE DENSITY; CATARACT; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE DEFECT; DEPRESSION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; DYSPNEA; FOLLOW UP; GLAUCOMA; HUMAN; MANIA; MEDICAL RESEARCH; PERCEPTION; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SENSITIVITY ANALYSIS; SIDE EFFECT; SYSTEMIC THERAPY;

ANTI-INFLAMMATORY AGENTS; ASTHMA; BIOMEDICAL RESEARCH; DYSPNEA; GLUCOCORTICOIDS; HUMANS; PERCEPTION;

EID: 34247578114     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.10.026     Document Type: Review

References (51)

1. Global Initiative for Asthma: Global strategy for asthma management and prevention. National Institutes of Health: National Heart, Lung, and Blood Institute. National Institutes of Health, Bethesda, MD; Updated 2005. Publication No. 02-3659.
2. Sin D.D., Man J., Sharpe H., et al. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis. JAMA 292 (2004) 367-376
3. Tattersfield A.E., Harrison T.W., Hubbard R.B., et al. Safety of inhaled corticosteroids. Proc Am Thorac Soc 1 (2004) 171-175
4. American Thoracic Society: Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med 159 (1999) 321-340
5. Rubinfeld A.R., and Pain M.C. Perception of asthma. Lancet 1 (1976) 882-884
6. Kikuchi Y., Okabe S., Tamura G., et al. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N Engl J Med 330 (1994) 1329-1334
7. Main J., Moss-Morris R., Booth R., et al. The use of reliever medication in asthma: the role of negative mood and symptom reports. J Asthma 40 (2003) 357-365
8. Dirks J.F., Schraa J.C., and Robinson S.K. Patient mislabelling of symptoms: implications for patient-physician communication and medical outcome. Int J Psychiatry Med 12 (1982) 15-27
9. Magadle R., Berar-Yanay N., and Weiner P. The risk of hospitalization and near-fatal and fatal asthma in relation to the perception of dyspnea. Chest 121 (2002) 329-333
10. Boulet L.P., Turcotte H., Cartier A., et al. Influence of beclomethasone and salmeterol on the perception of methacholine-induced bronchoconstriction. Chest 114 (1998) 373-379
11. Barnes P.J., and Adcock I.M. How do corticosteroids work in asthma?. Ann Intern Med 139 (2003) 359-370
12. Roisman G.L., Peiffer C., Lacronique J.G., et al. Perception of bronchial obstruction in asthmatic patients. Relationship with bronchial eosinophilic inflammation and epithelial damage and effect of corticosteroid treatment. J Clin Invest 96 (1995) 12-21
13. Laitinen L.A., and Laitinen A. Remodeling of asthmatic airways by glucocorticosteroids. J Allergy Clin Immunol 97 (1996) 153-158
14. Stuart F.A., Segal T.Y., and Keady S. Adverse psychological effects of corticosteroids in children and adolescents. Arch Dis Child 90 (2005) 500-506
15. Brown E.S., and Chandler P.A. Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry 3 (2001) 17-21
16. Bender B.G., and Milgrom H. Neuropsychological and psychiatric side effects of medications used to treat asthma and allergic rhinitis. In: Kaptein A.A., and Creer T.L. (Eds). Respiratory disorders and behavioural medicine (2002), Martin Dunitz, London 175-196
17. Brown E.S., Suppes T., Khan D.A., et al. Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharmacol 22 (2002) 55-61
18. Brown E.S., Woolston D.J., Frol A., et al. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry 55 (2004) 538-545
19. Put C., Van den Bergh O., Van Ongeval E., et al. Negative affectivity and the influence of suggestion on asthma symptoms. J Psychosom Res 57 (2004) 249-255
20. Put C., Demedts M., Van Den Bergh O., et al. Asthma symptoms: influence of personality versus clinical status. Eur Respir J 13 (1999) 751-756
21. Rietveld S., and Prins P.J. The relationship between negative emotions and acute subjective and objective symptoms of childhood asthma. Psychol Med 28 (1998) 407-415
22. Weiner P., Berar-Yanay N., Davidovich A., et al. The perception of dyspnoea in patients with asthma, before and following treatment with inhaled glucocorticosteroids. Respir Med 94 (2000) 161-165
23. Bijl-Hofland I.D., Cloosterman S.G.M., Folgering H.T.M., et al. Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma. Am J Respir Crit Care Med 164 (2001) 764-769
24. Salome C.M., Reddel H.K., Ware S.I., et al. Effect of budesonide on the perception of induced airway narrowing in subjects with asthma. Am J Respir Crit Care Med 165 (2002) 15-21
25. Salome C.M., Leuppi J.D., Freed R., et al. Perception of airway narrowing during reduction of inhaled corticosteroids and asthma exacerbation. Thorax 58 (2003) 1042-1047
26. Rietveld S., and Everaerd W. Perceptions of asthma by adolescents at home. Chest 117 (2000) 434-439
27. Higgs C.M.B., and Laszlo G. Influence of treatment with beclomethasone, cromoglycate and theophylline on perception of bronchoconstriction in patients with bronchial asthma. Clin Sci 90 (1996) 227-234
28. in't Veen J.C., Smits H.H., Ravensberg A.J., et al. Impaired perception of dyspnea in patients with severe asthma. Relation to sputum eosinophils. Am J Respir Crit Care Med 158 (1998) 1134-1141
29. Ottanelli R., Rosi E., Romagnoli I., et al. Do inhaled corticosteroids affect perception of dyspnea during bronchoconstriction in asthma?. Chest 120 (2001) 770-777
30. Noseda A., De Bruyne I., De Maertelaer V., et al. Does an IV bolus of methylprednisolone relieve dyspnea in asthma exacerbations?. Chest 118 (2000) 1530-1537
31. Kallas de Carvalho F., Filho J.T., Vianna E.O., et al. Do steroids interfere in dyspnoea sensation?. Respir Med 96 (2002) 511-514
32. Boushey H.A., Sorkness C.A., King T.S., et al. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 352 (2005) 1519-1528
33. O'Byrne P.M., Bisgaard H., Godard P.P., et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 171 (2005) 129-136
34. Pauwels R.A., Pedersen S., Busse W.W., et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 361 (2003) 1071-1076
35. Bijl-Hofland I.D., Cloosterman S.G., Folgering H.T., et al. Relation of the perception of airway obstruction to the severity of asthma. Thorax 54 (1999) 15-19
36. Jang A.S., and Choi I.S. Increased perception of dyspnea by inhalation of short acting beta2 agonist in patients with asthma of varying severity. Ann Allergy Asthma Immunol 84 (2000) 79-83
37. Sont J.K., Booms P., Bel E.H., et al. The severity of breathlessness during challenges with inhaled methacholine and hypertonic saline in atopic asthmatic subjects. The relationship with deep breath-induced bronchodilation. Am J Respir Crit Care Med 152 (1995) 38-44
38. Tetzlaff K., Leplow B., ten Thoren C., et al. Perception of dyspnea during histamine- and methacholine-induced bronchoconstriction. Respiration 66 (1999) 427-433
39. Bijl-Hofland I.D., Cloosterman S.G., van Schayck C.P., et al. Perception of respiratory sensation assessed by means of histamine challenge and threshold loading tests. Chest 117 (2000) 954-959
40. Verschelden P., Cartier A., L'Archeveque J., et al. Compliance with and accuracy of daily self-assessment of peak expiratory flows (PEF) in asthmatic subjects over a three month period. Eur Respir J 9 (1996) 880-885
41. Gannon P.F., Belcher J., Pantin C.F., et al. The effect of patient technique and training on the accuracy of self-recorded peak expiratory flow. Eur Respir J 14 (1999) 28-31
42. von Leupoldt A., and Dahme B. Differentiation between the sensory and affective dimension of dyspnea during resistive load breathing in normal subjects. Chest 128 (2005) 3345-3349
43. Wilson R.C., and Jones P.W. Differentiation between the intensity of breathlessness and the distress it evokes in normal subjects during exercise. Clin Sci 80 (1991) 65-70
44. Carrieri-Kohlman V., Gormley J.M., Douglas M.K., et al. Exercise training decreases dyspnea and the distress and anxiety associated with it. Monitoring alone may be as effective as coaching. Chest 110 (1996) 1526-1535
45. Meek P.M., Lareau S.C., and Hu J. Are self-reports of breathing effort and breathing distress stable and valid measures among persons with asthma, persons with COPD, and healthy persons?. Heart Lung 32 (2003) 335-346
46. Manning H.L., and Schwartzstein R.M. Respiratory sensations in asthma: physiological and clinical implications. J Asthma 38 (2001) 447-460
47. Banzett R.B., Dempsey J.A., O'Donnell D.E., et al. Symptom perception and respiratory sensation in asthma. Am J Respir Crit Care Med 162 (2000) 1178-1182
48. Boudreau D., Styhler A., Gray-Donald K., et al. A comparison of breathlessness during spontaneous asthma and histamine-induced bronchoconstriction. Clin Invest Med 18 (1995) 25-32
49. von Leupoldt A, Seemann N, Gugleva T, et al. Attentional distraction reduces the affective but not the sensory dimension of perceived dyspnea. Respir Med, in press, doi:10.1016/j.rmed.2006.06.033.
50. von Leupoldt A., Ambruzsova R., Nordmeyer S., et al. Sensory and affective aspects of dyspnea contribute differentially to the Borg scale's measurement of dyspnea. Respiration 73 (2006) 762-768
51. von Leupoldt A, Dahme B. Psychological aspects in the perception of dyspnea in obstructive pulmonary disease. Respir Med, in press, doi:10.1016/j.rmed.2006.06.011.